Antioxidants

Critical Care Nephrology, Second Edition

Volumn , Issue , 2008, Pages 435-438

  Singbartl, Kai ^a,b   Zarbock, Alexander ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052076448     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4252-5.50085-X     Document Type: Chapter

References (26)

1. KA Nath and SM Norby (2000) Reactive oxygen species and acute renal failure. Am J Med 109 665-678.
2. GH Metnitz, M Fischer, C Bartens, et al. (2000) Impact of acute renal failure on antioxidant status in multiple organ failure. Acta Anaesthesiol Scand 44 236-240.
3. J Himmelfarb, E McMonagle, S Freedman, et al. (2004) Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 15 2449-2456.
4. ML Aitio (2006) N-acetylcysteine: Passe-partout or much ado about nothing? Br J Clin Pharmacol 61 5-15.
5. S Fishbane, JH Durham, K Marzo and M Rudnick (2004) N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 15 251-260.
6. F Galli, L Ghibelli, U Buoncristiani, et al. (2003) Mononuclear leukocyte apoptosis in haemodialysis patients: The role of cell thiols and vitamin E. Nephrol Dial Transplant 18 1592-1600.
7. V Witko-Sarsat, V Gausson, A-T Nguyen, et al. (2003) AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: A potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 64 82-91.
8. F Stacul, A Adam, CR Becker, et al. (2006) Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 98 59K-77K.
9. U Hoffmann, M Fischereder, B Kruger, et al. (2004) The value of N-acetylcysteine in the prevention of radiocontrast agent–induced nephropathy seems questionable. J Am Soc Nephrol 15 407-410.
10. A Zagler, M Azadpour, C Mercado and CH Hennekens (2006) N-acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trials. Am Heart J 151 140-145.
11. KEA Burns, MWA Chu, RJ Novick, et al. (2005) Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: A randomized controlled trial. JAMA 294 342-350.
12. A Ristikankare, T Kuitunen, A Kuitunen, et al. (2006) Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 97 611-616.
13. K Spargias, E Alexopoulos, S Kyrzopoulos, et al. (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110 2837-2842.
14. M Endres (2006) Statins: Potential new indications in inflammatory conditions. Atheroscler Suppl 7 31-35.
15. S Wolfrum, KS Jensen and JK Liao (2003) Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 23 729-736.
16. N Attallah, L Yassine, J Musial, et al. (2004) The potential role of statins in contrast nephropathy. Clin Nephrol 62 273-278.
17. S Khanal, N Attallah, DE Smith, et al. (2005) Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med 118 843-849.
18. MC Ruiz, JM Moreno, N Ruiz, et al. (2006) Effect of statin treatment on oxidative stress and renal function in renal transplantation. Transplant Proc 38 2431-2433.
19. K Doi, Y Suzuki, A Nakao, et al. (2004) Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney. Kidney Int 65 1714-1723.
20. M Satoh, N Kashihara, S Fujimoto, et al. (2003) A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo. J Pharmacol Exp Ther 305 1183-1190.
21. K Mori, HT Lee, D Rapoport, et al. (2005) Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115 610-621.
22. J Pincemail, JO Defraigne, O Detry, et al. (2000) Ischemia-reperfusion injury of rabbit kidney: Comparative effects of desferrioxamine and N-acetylcysteine as antioxidants. Transplant Proc 32 475-476.
23. PR Dragsten, PE Hallaway, GJ Hanson, et al. (2000) First human studies with a high-molecular-weight iron chelator. J Lab Clin Med 135 57-65.
24. B de Vries, SJ Walter, L von Bonsdorff, et al. (2004) Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. Transplantation 77 669-675.
25. J Mishra, C Dent, R Tarabishi, et al. (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 1231-1238.
26. J Mishra, K Mori, Q Ma, et al. (2004) Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15 3073-3082.